These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21519170)

  • 1. [Intestinal thrombotic microangiopathy after liver transplantation].
    Kim ER; Kim KM
    Korean J Gastroenterol; 2011 Mar; 57(3):198-200. PubMed ID: 21519170
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy.
    Carson JM; Newman ED; Farber JL; Filippone EJ
    Clin Nephrol; 2012 Jan; 77(1):79-84. PubMed ID: 22185974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy-Is the culprit what we think it is?
    Petr V; Zahradka I; Viklicky O
    Am J Transplant; 2024 Sep; 24(9):1708-1709. PubMed ID: 38677652
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombotic microangiopathy associated with tacrolimus in lung transplantation.
    Reig Mezquida JP; Jover AS; Ansótegui Barrera E; Escrivá Peiró J; Pastor Colom MD; Pastor Guillem J
    Arch Bronconeumol; 2015 May; 51(5):e23-4. PubMed ID: 25138798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Barkholt L; Linde A; Falk KI
    Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful sirolimus rescue in tacrolimus-induced thrombotic microangiopathy after living-related liver transplantation.
    Czubkowski P; Pawłowska J; Jankowska I; Teisseyre M; Kamińska D; Markiewicz M; Ryżko J
    Pediatr Transplant; 2012 Sep; 16(6):E261-4. PubMed ID: 22066835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients.
    Nwaba A; MacQuillan G; Adams LA; Garas G; Delriviere L; Augustson B; DeBoer B; Moody H; Jeffrey GP
    Intern Med J; 2013 Mar; 43(3):328-33. PubMed ID: 23441660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab.
    Morales E; Rabasco C; Gutierrez E; Praga M
    Transpl Int; 2015 Jul; 28(7):878-80. PubMed ID: 25712140
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
    Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-induced thrombotic microangiopathy post-liver transplantation for cryptogenic acute liver failure in an infant.
    Wujek C; Fishel Ben-Kenan R; Kothari A; Wadera S; Sacco KA
    Ann Hematol; 2023 Mar; 102(3):687-688. PubMed ID: 36527459
    [No Abstract]   [Full Text] [Related]  

  • 11. The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy.
    Gabr JB; Bilal H; Mirchia K; Perl A
    J Investig Med High Impact Case Rep; 2020; 8():2324709620947266. PubMed ID: 32757799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.
    Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R
    Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting.
    Kharfan-Dabaja MA; Pidala J; Anasetti C
    Blood; 2010 May; 115(21):4316-7; author reply 4317. PubMed ID: 20508174
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipient.
    Boyer NL; Niven A; Edelman J
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23396921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
    Berenguer M; Aguilera V; San Juan F; Benlloch S; Rubin A; López-Andujar R; Moya A; Pareja E; Montalva E; Yago M; de Juan M; Mir J; Prieto M
    Transplantation; 2010 Dec; 90(11):1204-9. PubMed ID: 21068701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
    Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy syndromes.
    Zakarija A
    Cancer Treat Res; 2009; 148():115-36. PubMed ID: 19377922
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
    Klintmalm GB; Davis GL; Teperman L; Netto GJ; Washburn K; Rudich SM; Pomfret EA; Vargas HE; Brown R; Eckhoff D; Pruett TL; Roberts J; Mulligan DC; Charlton MR; Heffron TG; Ham JM; Douglas DD; Sher L; Baliga PK; Kinkhabwala M; Koneru B; Abecassis M; Millis M; Jennings LW; Fasola CG
    Liver Transpl; 2011 Dec; 17(12):1394-403. PubMed ID: 21850690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
    Pérez Calle JL; Salcedo M; Núñez O; Barrio J; Bañares R; de Diego A; Alvarez E; Palomo J; Clemente G
    Gastroenterol Hepatol; 2003 Jan; 26(1):26-8. PubMed ID: 12525325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.